/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

C

Carl Hay

AstraZeneca (United States)(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

28

Papers

2.5K

Citations

17

h-index

19

i10-index

Carl Hay is an academic researcher from AstraZeneca (United States). The author has contributed to research in topics: Adenosine and Purinergic Signaling & Virus-based gene therapy research & Monoclonal and Polyclonal Antibodies Research. The author has an h-index of 17, co-authored 24 publications.

Research Topics

Adenosine and Purinergic Signaling Virus-based gene therapy research Monoclonal and Polyclonal Antibodies Research RNA Interference and Gene Delivery Cancer Research and Treatments

Papers by this author

works

Seneca Valley Virus, a Systemically Deliverable Oncolytic Picornavirus, and the Treatment of Neuroendocrine Cancers

2007 · JNCI Journal of the National Cancer Institute · 250 citations

https://doi.org/10.1093/jnci/djm198

P. Seshidhar Reddy Kevin D. Burroughs Laura M. Hales Shanthi Ganesh

Combining phenotypic and proteomic approaches to identify membrane targets in a ‘triple negative’ breast cancer cell type

2013 · Molecular Cancer · 50 citations

https://doi.org/10.1186/1476-4598-12-11

Steven Rust Sandrine Guillard Kris F. Sachsenmeier Carl Hay

Research topics

topics

Adenosine and Purinergic Signaling

Virus-based gene therapy research

Monoclonal and Polyclonal Antibodies Research

RNA Interference and Gene Delivery

Cancer Research and Treatments

Chat about Author

Papers

Chat

Click to start Chat